Tsaktanis T, Beyer T, Nirschl L, Linnerbauer M, Grummel V, Bussas M, et al
In head-to-head clinical trial comparisons, semaglutide delivered 14.9% average weight loss at 68 weeks, while retatrutide achieved 24.2% weight loss at 48 weeks
What side effects should I talk to my provider about
Patients on combination therapy should be closely monitored, and adjustments to the dosing of these medications may be necessary to minimize the risk of hypoglycemia
some might not notice the appetite-suppressing effects immediately
Patients with neurological conditions affecting bladder control Older adults, who may have reduced bladder function Those on higher doses of baclofen or those combining it with other medications that affect the urinary system Early recognition of urinary retention is important to prevent complications